SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-011988
Filing Date
2023-01-20
Accepted
2023-01-20 16:05:58
Documents
12
Period of Report
2023-01-19
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d424427d8k.htm   iXBRL 8-K 22320
  Complete submission text file 0001193125-23-011988.txt   147443

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bior-20230119.xsd EX-101.SCH 2868
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bior-20230119_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bior-20230119_pre.xml EX-101.PRE 11719
6 EXTRACTED XBRL INSTANCE DOCUMENT d424427d8k_htm.xml XML 3479
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39334 | Film No.: 23541011
SIC: 2834 Pharmaceutical Preparations